We can help addressing your challenges through
Significant reduction of API dosage for:
Targeted APIs delivery.
Optimizing therapies.
- Reduction or elimination of Adverse Drug Reactions (“ADR”)
- Pediatric and Neonatal therapiesNew therapies
- New therapies
Targeted APIs delivery.
- Efficient crossing of the Blood Brain Barrier
- Boosting the efficacy of antineoplastic APIs
- Efficient intracellular therapies
Optimizing therapies.
Partnership structuring
- Licensing
- Joint development
- Drug production
Our innovations are pointed towards Unique, Versatile, High Added Value, and Niche Products.